Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12061)
All Articles published online
|
Publishing Process of This Article
|
Jul 26, 2019 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, Durá AB, Suárez P, Iranzo I, Gil-Raga M, Burgos CB, Sempere J. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases 2019; 7(14): 1732-1752 [PMID: 31417920 DOI: 10.12998/wjcc.v7.i14.1732] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i14/1732.htm |
| Number | Citing Articles |
| 1 |
Alireza Nemati, Mohamad Sadegh Aghajanzadeh, Mahdi Rooberahan. An Overview on Cancer Diagnosis based on Antibody-Based Immune Techniques. Modern Medical Laboratory Journal 2020; 3(2): 100 doi: 10.30699/mmlj17.3.1.100
|
| 2 |
Dina Ioffe, Pooja Phull, Efrat Dotan. Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review. Cancer Management and Research 2021; : 8085 doi: 10.2147/CMAR.S276104
|
| 3 |
Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, Nasim Rashedi, Saeideh Allahyari, Nastaran Hashemzadeh. Principles of Biomaterials Encapsulation : Volume Two. 2023; : 589 doi: 10.1016/B978-0-12-824345-9.00019-2
|
| 4 |
Kim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff, Angele Kotomale, Michael Rodriguez, Bruce Feinberg, Haobo Ren, Mike Blecker, Richard Kim. Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US. The Oncologist 2024; doi: 10.1093/oncolo/oyae204
|
| 5 |
Cosmas Rinaldi Adithya Lesmana, Baiq Kirana D. Mandasari. Immunosuppression. 2020; doi: 10.5772/intechopen.94754
|
| 6 |
Hiroki Inada, Hideaki Miyamoto, Satoru Shinriki, Hisanobu Oda, Satoshi Narahara, Motohiro Yoshinari, Katsuya Nagaoka, Daiki Yoshii, Kotaro Fukubayashi, Hiromitsu Hayashi, Hideo Baba, Kisato Nosaka, Yasuhito Tanaka. Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer. International Journal of Clinical Oncology 2024; 29(12): 1908 doi: 10.1007/s10147-024-02616-x
|
| 7 |
Purva Gopal, Marie E. Robert, Xuchen Zhang. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine. Archives of Pathology & Laboratory Medicine 2024; 148(3): 359 doi: 10.5858/arpa.2022-0537-RA
|
| 8 |
Nhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, Sebastiao N. Martins-Filho, Quan Li, Melania Pintilie, Jessica Weiss, Vibha Raghavan, Michael Cabanero, Robert E. Denroche, Julie M. Wilson, Cristiane Metran-Nascente, Ayelet Borgida, Shawn Hutchinson, Anna Dodd, Michael Begora, Dianne Chadwick, Stefano Serra, Jennifer J. Knox, Steven Gallinger, David W. Hedley, Lakshmi Muthuswamy, Ming-Sound Tsao. Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90049-1
|
| 9 |
Milind Javle, Sunyoung Lee, Nilofer S Azad, Mitesh J Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora Janjan, Shreekant Parasuraman, Tanios S Bekaii-Saab. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017. The Oncologist 2022; 27(10): 874 doi: 10.1093/oncolo/oyac150
|
| 10 |
Josep Darbà, Alicia Marsà. Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018). Expert Review of Pharmacoeconomics & Outcomes Research 2021; 21(3): 425 doi: 10.1080/14737167.2021.1842201
|
| 11 |
Yawei Qian, Wenyu Jia, Hongda Liu. Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1301416
|
| 12 |
Ruochen Ying, Anmol Mittal, Kaveh Hajifathalian. Rare Manifestation of Pancreaticobiliary Cancer With Extrahepatic Lesions. Cureus 2023; doi: 10.7759/cureus.43276
|
| 13 |
T.O. Goetze, C. Roderburg, F.W. Friedrich, J. Trojan. New perspectives in biliary tract cancers. ESMO Gastrointestinal Oncology 2024; 5: 100092 doi: 10.1016/j.esmogo.2024.100092
|
| 14 |
Ji Hye Jung, So Jeong Yoon, Ok Joo Lee, Sang Hyun Shin, In Woong Han, Jin Seok Heo. Surgical outcomes and prognostic factors of distal common bile duct adenocarcinoma: chronological analysis in a single high-volume institutional experience. BMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01649-1
|
| 15 |
Filippo de Braud, Juan Valle, Angela Lamarca, David Malka, Antoine Hollebecque. Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised Medicine. EMJ Oncology 2022; : 2 doi: 10.33590/emjoncol/10184268
|
| 16 |
Gülşah BAYRAM ILIKAN, İlkay AKMANGİT. Percutaneous Transhepatic Cholangiography, Percutaneous Biliary Drainage and Metallic Endoprotesis Applications in Malign Biliary Obstructions. Journal of Contemporary Medicine 2021; 11(1): 97 doi: 10.16899/jcm.764141
|
| 17 |
Jieling Zheng, Shaobo Yao. [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer. European Journal of Nuclear Medicine and Molecular Imaging 2020; 47(9): 2078 doi: 10.1007/s00259-020-04847-2
|
| 18 |
Tanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J Borad, Ghassan K Abou-Alfa, Ping Jiang, Christine F Lihou, Huiling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel.
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with
FGFR2
rearrangements
. Future Oncology 2020; 16(30): 2385 doi: 10.2217/fon-2020-0429
|
| 19 |
Ghassan K. Abou-Alfa, Kristen Bibeau, Nikolaus Schultz, Amin Yaqubie, Brittanie Millang, Haobo Ren, Luis Féliz. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma. Targeted Oncology 2022; 17(5): 517 doi: 10.1007/s11523-022-00906-w
|